✦ LIBER ✦

Combined modality therapy for the treatment of invasive bladder cancer

✍ Scribed by William U. Shipley

Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 124 KB
Volume: 21
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(91)90406-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined modality therapy for the treatm

Combined modality therapy for the treatment of invasive bladder cancer

✍ William U. Shipley; Anthony L. Zietman 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 226 KB

2018 Selective bladder preservation by c

2018 Selective bladder preservation by combined modality therapy for invasive bladder cancer

✍ L.A. Kachnic; D.S. Kaufman; A.L. Zietman; K.C. Dallow; P.P. Griffin; N.M. Heney; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Combined modality treatment of bladder c

Combined modality treatment of bladder cancer

✍ Derek Raghavan 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Opportunities with combined modality the

Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer

✍ Colvett, Kyle T.; Althausen, Alex F.; Bassil, Barbara; Heney, Niall M.; McGovern 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

Combined-modality therapy for organ preservation represents an appropriate alternative to radical surgery in the management of several malignant diseases. The standard therapy for muscle-invasive bladder cancer in the United States has been radical cystectomy. Although the sequelae of radical surger

Bladder-sparing, combined-modality appro

Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer : A multi-institutional, long-term experience

✍ Sisto Perdonà; Riccardo Autorino; Rocco Damiano; Marco De Sio; Brunello Morrica; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract ## BACKGROUND. The authors evaluated their long‐term experience with combined‐modality, conservative treatment in patients with muscle‐invasive bladder cancer. ## METHODS. In total, 121 patients with T2, T3, or T4 bladder cancer (mean age, 63 years; ratio of men to women, 3:1) underw

Combined modality treatment of pancreati

Combined modality treatment of pancreatic cancer: Implications for the surgeon

✍ Dr. Urs F. Metzger; Daniel L. Kisner; Bimal C. Ghosh 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

Since pancreatic cancer is still increasing and has a poor prognosis, there is great interest in improving treatment results by combined modality approaches. This paper considers the most appropriate studies to analyze the status of treatment and future implications for surgeons. With new radiation